Skip to content

Study · Animal study (in vivo) · mouse · 1982

3 results

Modulation of mouse natural killer cell activity by the serum thymic factor.

Bardos P, Bach JF

Scandinavian journal of immunology1 Oct 1982Cited by 20 (Europe PMC)

PMID6983118 (opens in a new tab)DOI10.1111/j.1365-3083.1982.tb00730.x (opens in a new tab)PepBankPUB-06983118
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Activity measurement

    FTS increased NK activity in C57BL/6, BALB/c, A and nu/nu mice, depending on treatment duration and strain.

    In plain wordsIn mice of four strains, FTS increased natural killer activity, depending on treatment duration and strain.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    IncreaseNK activity in C57BL/6, BALB/c, A and nu/nu mice
    Study

    mousen: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    After mice had been treated with serum thymic factor (FTS), we observed an increase or a decrease in the NK activity, depending on the duration of treatment and mouse strain: an increase of C57BL/6, BALB/c, A, and nu/nu, and a decrease for NZB and CBA mice.
  2. 02AnimalAnimal study (in vivo)Activity measurement

    FTS decreased NK activity in NZB and CBA mice, depending on treatment duration and strain.

    In plain wordsIn NZB and CBA mice, FTS decreased natural killer activity, depending on treatment duration and strain.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    DecreaseNK activity in NZB and CBA mice
    Study

    mousen: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    After mice had been treated with serum thymic factor (FTS), we observed an increase or a decrease in the NK activity, depending on the duration of treatment and mouse strain: an increase of C57BL/6, BALB/c, A, and nu/nu, and a decrease for NZB and CBA mice.
  3. 03AnimalAnimal study (in vivo)Activity measurement

    In thymectomized mice, FTS returned augmented NK activity to normal levels.

    In plain wordsIn thymectomized mice, FTS returned increased natural killer activity to normal levels.

    Peptide
    Thymulin (serum thymic factor)
    Outcome
    DecreaseNK activity after thymectomy
    Study

    mousen: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The fact that treatment of C57BL/6 mice with FTS produces the same effects as thymectomy--that is, an increase--on the NK activity and returns the augmented NK activity of thymectomized mice to normal levels

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.